Good Medicine Podcast
Podcast Description
The science behind what makes medicine...good
Podcast Insights
Content Themes
The podcast focuses on topics such as pharmacology, medical ethics, and the role of technology in healthcare, with episodes exploring the effectiveness of new pharmaceuticals and discussing the impact of telemedicine on patient care. Specific episode examples include dives into the science of vaccine development and discussions on the implications of personalized medicine.

The science behind what makes medicine…good
For decades, the United States has been a global leader in pharmaceutical innovation. But as clinical trials become increasingly expensive and time-consuming, could that leadership be at risk?
In this episode of the Good Medicine Podcast, Dr. David Bearss explores the growing international competition in clinical research and what it could mean for the future of medicine.
America's success in pharmaceutical development has been driven in part by an economy willing to take enormous financial risks. Developing a new drug requires substantial investment, years of research, and no guarantee of success. It's a high-stakes environment where many investments fail, but a successful breakthrough can change medicine.
However, that same system now faces growing challenges. Clinical trials in the United States have become increasingly costly and complex, creating opportunities for other countries to attract research investment and accelerate drug development.
Dave discusses how the United States may be becoming a victim of its own success, why other countries are positioning themselves to compete, and what could happen if the center of pharmaceutical innovation continues to shift.
For American patients, the consequences could extend beyond economics. If research and development increasingly move overseas, it could eventually affect access to clinical trials, emerging treatments, and the benefits of being at the forefront of medical discovery.
The question is no longer just who develops the next breakthrough. It's where that breakthrough will happen and who will benefit first.
Topics covered include:
• Why the United States became a leader in pharmaceutical innovation
• The financial risks involved in drug development
• Why clinical trials have become so expensive and time-consuming
• Growing international competition for clinical research
• How other countries are attracting pharmaceutical investment
• What shifting innovation could mean for American patients
• The future of US leadership in medicine
🎧 Listen on Spotify and Apple Podcasts📺 Subscribe for more conversations on science, medicine, and health.
Thank you to our sponsors
BioHive: https://www.biohive.com
Galvan: https://galvan.sng.link/D4mh8/oe8k/litt
Follow Good Medicine Podcast
Insta: https://www.instagram.com/good.medicine.podcast/
X: https://x.com/GoodMedicinePod
TikTok: https://www.tiktok.com/@good.medicine.podcast
LinkedIn: https://www.linkedin.com/company/goodmedicinepodcast/

Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.